Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review

RATIONALE: Immune checkpoint inhibitors have led to the development of new approaches for cancer treatment with positive outcomes. However, checkpoint blockade is associated with a unique spectrum of immune-related adverse events (irAEs), which may cause irreversible neurological deficits and even d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Hung, Lee, Kang-Yun, Hu, Chaur-Jong, Chung, Chen-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815782/
https://www.ncbi.nlm.nih.gov/pubmed/29390370
http://dx.doi.org/10.1097/MD.0000000000009262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815782/
https://www.ncbi.nlm.nih.gov/pubmed/29390370
http://dx.doi.org/10.1097/MD.0000000000009262

Ejemplares similares